Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
0Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
NeuroSense Therapeutics Ltd. (NRSN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
3Total relationships
0Distinct source URLs
3High confidence
0.900Average confidence
2026-07-01Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
NeuroSense Therapeutics Ltd. Suppliers
No suppliers on recordNeuroSense Therapeutics Ltd. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.
NeuroSense Therapeutics Ltd. Customers
No clients on recordNeuroSense Therapeutics Ltd. does not appear to disclose named customer relationships in its verified regulatory filings. Many companies do not publicly name customers in regulatory disclosures.
NeuroSense Therapeutics Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
NRSN-DEBT-11368
Warrants outstanding: 3000000
90%
xbrl warrant detail from xbrl 2025-12-31.
NRSN-DEBT
Debt stack $170,000
90%
Market cache reports total debt of $170,000.
NeuroSense Therapeutics Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for NeuroSense Therapeutics Ltd..
NeuroSense Therapeutics Ltd. Ownership
Holder
Name
Confidence
Evidence
NRSN-OWNER-YORKVILLE-ADVISORS-GLOBAL-LP
Yorkville Advisors Global, LP
90%
13F overlay lists Yorkville Advisors Global, LP as top holder; 14 tracked holders.
